Unichem Laboratories Limited (UNICHEMLAB.BO)
INR 568.35
(2.45%)
INR 568.35
(2.45%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -704.74 Million INR | 65.15% |
| 2022 | -2.02 Billion INR | -711.67% |
| 2021 | 330.61 Million INR | -3.68% |
| 2020 | 343.24 Million INR | 157.03% |
| 2019 | -601.82 Million INR | -152.86% |
| 2018 | -238 Million INR | -100.94% |
| 2017 | 25.44 Billion INR | 2241.76% |
| 2016 | 1.08 Billion INR | 0.53% |
| 2015 | 1.08 Billion INR | 43.4% |
| 2014 | 753.9 Million INR | -55.47% |
| 2013 | 1.69 Billion INR | 49.53% |
| 2012 | 1.13 Billion INR | 58.9% |
| 2011 | 712.57 Million INR | -24.98% |
| 2010 | 949.8 Million INR | -22.66% |
| 2009 | 1.22 Billion INR | 13.55% |
| 2008 | 1.08 Billion INR | 112.56% |
| 2007 | 508.82 Million INR | -27.57% |
| 2006 | 702.49 Million INR | -12.52% |
| 2005 | 803.03 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 92.55 Million INR | 107.16% |
| 2023 Q4 | -1.29 Billion INR | -253.96% |
| 2023 FY | -704.74 Million INR | 65.15% |
| 2023 Q1 | -6.68 Million INR | 98.49% |
| 2023 Q2 | -244.87 Million INR | -3564.21% |
| 2023 Q3 | 839.9 Million INR | 442.99% |
| 2022 Q4 | -442.65 Million INR | 30.76% |
| 2022 Q1 | -233.68 Million INR | -132.7% |
| 2022 Q2 | -706.66 Million INR | -202.4% |
| 2022 Q3 | -639.27 Million INR | 9.54% |
| 2022 FY | -2.02 Billion INR | -711.67% |
| 2021 Q3 | -141.04 Million INR | -10.05% |
| 2021 FY | 330.61 Million INR | -3.68% |
| 2021 Q4 | 714.72 Million INR | 606.72% |
| 2021 Q2 | -128.16 Million INR | -11.56% |
| 2021 Q1 | -114.88 Million INR | -2711.75% |
| 2020 Q2 | 87.38 Million INR | 258.95% |
| 2020 Q3 | 235.6 Million INR | 169.63% |
| 2020 Q4 | -4.08 Million INR | -101.73% |
| 2020 Q1 | 24.34 Million INR | 114.16% |
| 2020 FY | 343.24 Million INR | 157.03% |
| 2019 Q4 | -171.88 Million INR | -17.75% |
| 2019 Q3 | -145.97 Million INR | 34.27% |
| 2019 Q2 | -222.08 Million INR | -258.89% |
| 2019 Q1 | -61.88 Million INR | -116.29% |
| 2019 FY | -601.82 Million INR | -152.86% |
| 2018 FY | -238 Million INR | -100.94% |
| 2018 Q4 | 379.91 Million INR | 12667.45% |
| 2018 Q3 | -3.02 Million INR | 99.26% |
| 2018 Q2 | -410.32 Million INR | -100.58% |
| 2018 Q1 | -204.57 Million INR | -760.7% |
| 2017 FY | 25.44 Billion INR | 2241.76% |
| 2017 Q4 | -23.76 Million INR | 0.0% |
| 2016 Q4 | 290.1 Million INR | 0.0% |
| 2016 FY | 1.08 Billion INR | 0.53% |
| 2015 FY | 1.08 Billion INR | 43.4% |
| 2014 FY | 753.9 Million INR | -55.47% |
| 2013 FY | 1.69 Billion INR | 49.53% |
| 2012 FY | 1.13 Billion INR | 58.9% |
| 2011 FY | 712.57 Million INR | -24.98% |
| 2010 FY | 949.8 Million INR | -22.66% |
| 2009 FY | 1.22 Billion INR | 13.55% |
| 2008 FY | 1.08 Billion INR | 112.56% |
| 2007 FY | 508.82 Million INR | -27.57% |
| 2006 FY | 702.49 Million INR | -12.52% |
| 2005 FY | 803.03 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 100.736% |
| NATCO Pharma Limited | 13.88 Billion INR | 105.076% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 123.469% |
| Syncom Formulations (India) Limited | 253.14 Million INR | 378.398% |
| Achyut Healthcare Limited | 5.73 Million INR | 12394.888% |
| Ajanta Pharma Limited | 8.16 Billion INR | 108.635% |
| Alkem Laboratories Limited | 17.95 Billion INR | 103.924% |
| Alpa Laboratories Limited | 167.76 Million INR | 520.077% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 111.444% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 143.635% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 102.221% |
| Bajaj HealthCare Limited | -837.93 Million INR | 15.895% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 193.4% |
| Brooks Laboratories Limited | -195.91 Million INR | -259.711% |
| Divi's Laboratories Limited | 16 Billion INR | 104.405% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 101.266% |
| Eris Lifesciences Limited | 3.91 Billion INR | 117.979% |
| FDC Limited | 3.05 Billion INR | 123.089% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 95.307% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 114.966% |
| Granules India Limited | 4.05 Billion INR | 117.388% |
| Gufic Biosciences Limited | 861.35 Million INR | 181.818% |
| Hester Biosciences Limited | 188.89 Million INR | 473.097% |
| Indoco Remedies Limited | 984.6 Million INR | 171.577% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 116.741% |
| Ipca Laboratories Limited | 5.47 Billion INR | 112.876% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 413.735% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | -257.223% |
| Lasa Supergenerics Limited | -217.3 Million INR | -224.309% |
| Laurus Labs Limited | 1.6 Billion INR | 143.896% |
| Lupin Limited | 19.14 Billion INR | 103.681% |
| Mankind Pharma Limited | 19.12 Billion INR | 103.684% |
| Medicamen Biotech Limited | 109.31 Million INR | 744.72% |
| Medico Remedies Limited | 82.9 Million INR | 950.02% |
| Megasoft Limited | -127.46 Million INR | -452.887% |
| Piramal Pharma Limited | 178.2 Million INR | 495.479% |
| RPG Life Sciences Limited | 876.6 Million INR | 180.395% |
| Sigachi Industries Limited | 571.8 Million INR | 223.249% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 81.8% |
| Wanbury Limited | 559.56 Million INR | 225.945% |
| Windlas Biotech Limited | 581.87 Million INR | 221.117% |
| ZIM Laboratories Limited | 172.46 Million INR | 508.632% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 101.826% |
| Procter & Gamble Health Limited | 2 Billion INR | 135.065% |
| Amrutanjan Health Care Limited | 449.72 Million INR | 256.705% |
| Bal Pharma Limited | 73.92 Million INR | 1053.36% |
| Strides Pharma Science Limited | -706.14 Million INR | 0.198% |
| Venus Remedies Limited | 284.9 Million INR | 347.358% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 132.491% |
| Nectar Lifesciences Limited | 49.95 Million INR | 1510.897% |
| Shilpa Medicare Limited | 318.74 Million INR | 321.101% |
| Aarti Drugs Limited | 1.71 Billion INR | 141.112% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 152.425% |
| Suven Life Sciences Limited | -1.05 Billion INR | 32.93% |
| Ind-Swift Limited | 142.31 Million INR | 595.206% |
| Valiant Laboratories Limited | 3.19 Million INR | 22150.782% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 112.753% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 87.579% |
| Themis Medicare Limited | 435.23 Million INR | 261.921% |
| Hikal Limited | 696.02 Million INR | 201.253% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 104.255% |
| Sequent Scientific Limited | -358.69 Million INR | -96.477% |
| Novartis India Limited | 851.9 Million INR | 182.726% |
| Wockhardt Limited | -4.63 Billion INR | 84.779% |
| Jubilant Pharmova Limited | 771 Million INR | 191.406% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | 10037.155% |
| Neuland Laboratories Limited | 3 Billion INR | 123.485% |
| Morepen Laboratories Limited | 961.59 Million INR | 173.289% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | 582.654% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | -676.859% |